NDC 51662-1335
DILTIAZEM HCI
Diltiazem Hci
DILTIAZEM HCI is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Diltiazem Hydrochloride.
Product ID | 51662-1335_7d8e8b1e-f67c-57d2-e053-2991aa0a8d12 |
NDC | 51662-1335 |
Product Type | Human Prescription Drug |
Proprietary Name | DILTIAZEM HCI |
Generic Name | Diltiazem Hci |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2018-12-21 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA078538 |
Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Active Ingredient Strength | 5 mg/mL |
Pharm Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |